ADC Therapeutics SA (ADCT) vs Lyell Immunopharma, Inc. (LYEL)
- ADC Therapeutics SA ADCT 1.41 −5.37%
- Lyell Immunopharma, Inc. LYEL 8.12 −0.85%
ADC Therapeutics SA and Lyell Immunopharma, Inc. are both Biotechnology companies. ADC Therapeutics SA and Lyell Immunopharma, Inc. are of similar size ($200.7M and $190.2M). ADC Therapeutics SA grew revenue faster over the last twelve months: 3.03% against −55.0%. ADC Therapeutics SA has the higher net margin (−121.8% vs −920,285.2%) and the higher return on invested capital (0.00% vs −539.5%). Across the 17 metrics below, ADC Therapeutics SA leads on 12 and Lyell Immunopharma, Inc. on 5.
Valuation
Profitability
| Metric | ADCT | LYEL | Biotechnology median |
|---|---|---|---|
| Gross margin | 88.86% | 100.00% | 65.16% |
| Operating margin | (125.08%) | (949,981.48%) | 0.00% |
| Net margin | (121.77%) | (920,285.19%) | 0.00% |
| Free cash flow margin | (127.72%) | (647,681.48%) | 0.00% |
| Return on equity | 45.35% | (93.28%) | (56.36%) |
| Return on assets | (32.25%) | (71.34%) | (48.04%) |
| Return on invested capital | 0.00% | (539.53%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack